Characterization of β-Sitosterol for Potential Selective GR Modulation

Protein Pept Lett. 2021;28(3):276-281. doi: 10.2174/0929866527666200813204833.

Abstract

Background: Although glucocorticoids (GCs) are characterized as powerful agents to treat inflammatory afflictions, they are accompanied by metabolic side effects which limit their usage. β-Sitosterol, as a minor component found in extraction of vegetable oil, was reported to have anti-inflammatory effects in RAW 264.7 cells.

Objective: To test whether β-sitosterol has an effect to dissociate transrepression from transactivation as a selective novel GR binder, this work evaluated the dissociated characteristics of β-sitosterol.

Methods: The probable binding interaction between β-sitosterol and GR was explored by molecular docking. The GR transcriptional activity of β-sitosterol was assessed in the reporter gene assay. The ability of β-sitosterol to modulate the transactivation and transrepression of GR was evaluated by real-time quantitative PCR analysis.

Results and discussion: In the present study, β-sitosterol treatment cannot induce GR-mediated transactivation. β-Sitosterol exerted a potential to inhibited the expression of GR target transrepressed gene without activating the expression of GR transactivation dependent gene. Molecular docking demonstrated that β-Sitosterol was able to bind the ligand binding domain of GR but unable to induce GR activation.

Conclusion: This work offers evidence that β-sitosterol may serve as a selective GR modulator.

Keywords: Glucocorticoid receptor; dissociate; molecular docking.; transactivation; transrepression; β-sitosterol.

MeSH terms

  • Animals
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • Mice
  • Molecular Docking Simulation*
  • RAW 264.7 Cells
  • Receptors, Glucocorticoid / chemistry*
  • Receptors, Glucocorticoid / metabolism
  • Sitosterols / chemistry*
  • Sitosterols / metabolism

Substances

  • Receptors, Glucocorticoid
  • Sitosterols
  • gamma-sitosterol